These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2859424)

  • 21. Evaluation of estrogen dependency of human breast cancers. II. Clinical evaluation of tamoxifen in advanced primary and recurrent breast cancer.
    Nishiki M; Yamane M; Amano K; Yasuda K; Okumichi T; Ezaki H
    Hiroshima J Med Sci; 1984 Jun; 33(2):163-6. PubMed ID: 6480380
    [No Abstract]   [Full Text] [Related]  

  • 22. ERICA predicts response to tamoxifen in elderly women with breast cancer.
    Davies N; Moir G; Carpenter R; Cuthbert A; Herbert A; Royle GT; Taylor I
    Ann R Coll Surg Engl; 1991 Nov; 73(6):361-3. PubMed ID: 1759765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancer.
    Anderson ED; Forrest AP; Levack PA; Chetty U; Hawkins RA
    Br J Cancer; 1989 Aug; 60(2):223-6. PubMed ID: 2527549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast cancer--which patients?
    Stewart HJ
    Horm Res; 1989; 32 Suppl 1():181-2. PubMed ID: 2613204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tamoxifen in early breast cancer.
    Bryce CJ
    Lancet; 1998 Aug; 352(9125):403. PubMed ID: 9717952
    [No Abstract]   [Full Text] [Related]  

  • 26. Medroxyprogesterone acetate versus tamoxifen in the therapy of advanced breast cancer.
    Lorenz I; Mechl Z
    Neoplasma; 1985; 32(1):119-24. PubMed ID: 3157070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controlled trial of tamoxifen as adjuvant agent in management of early breast cancer. Interim analysis at four years by Nolvadex Adjuvant Trial Organisation.
    Lancet; 1983 Feb; 1(8319):257-61. PubMed ID: 6130291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tamoxifen as primary treatment of breast cancer in elderly or frail patients: a practical management.
    Allan SG; Rodger A; Smyth JF; Leonard RC; Chetty U; Forrest AP
    Br Med J (Clin Res Ed); 1985 Feb; 290(6465):358. PubMed ID: 3917820
    [No Abstract]   [Full Text] [Related]  

  • 29. Adjuvant chemotherapy of early breast cancer.
    Med Lett Drugs Ther; 1990 May; 32(818):49-50. PubMed ID: 2333039
    [No Abstract]   [Full Text] [Related]  

  • 30. Adjuvant therapy with tamoxifen in operable breast cancer. 10 year results of the Naples (GUN) study.
    Bianco AR; De Placido S; Gallo C; Pagliarulo C; Marinelli A; Petrella G; D'Istria M; Delrio G
    Lancet; 1988 Nov; 2(8620):1095-9. PubMed ID: 2903322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant tamoxifen in the management of operable breast cancer: the Scottish Trial. Report from the Breast Cancer Trials Committee, Scottish Cancer Trials Office (MRC), Edinburgh.
    Lancet; 1987 Jul; 2(8552):171-5. PubMed ID: 2885637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consensus: use of estrogen receptor assay.
    Check WA
    JAMA; 1979 Oct; 242(16):1714-6. PubMed ID: 480590
    [No Abstract]   [Full Text] [Related]  

  • 33. Rational approaches to the hormonal treatment of breast cancer.
    Allegra JC
    Semin Oncol; 1983 Dec; 10(4 Suppl 4):25-8. PubMed ID: 6669986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Results of anti-estrogen therapy in metastatic breast cancer (preliminary results). Part II].
    Firusian N; Schmidt CG
    Med Welt; 1977 Dec; 28(51-52):2065-7. PubMed ID: 414049
    [No Abstract]   [Full Text] [Related]  

  • 35. Meeting highlights: adjuvant therapy for breast cancer.
    Glick JH
    J Natl Cancer Inst; 1988 Jun; 80(7):471-5. PubMed ID: 3367387
    [No Abstract]   [Full Text] [Related]  

  • 36. Relationship of oestrogen-receptor status to survival in breast cancer.
    Bishop HM; Blamey RW; Elston CW; Haybittle JL; Nicholson RI; Griffiths K
    Lancet; 1979 Aug; 2(8137):283-4. PubMed ID: 88612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Basic Consensus on endocrinotherapy for breast cancer].
    Jiang ZF; Xu BH; Song ST
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):238-9. PubMed ID: 16875616
    [No Abstract]   [Full Text] [Related]  

  • 38. Is there a seasonal variation in oestrogen receptor levels in human breast carcinoma tissues?
    Hähnel R; Parasiliti R; Twaddle E; Woodings T
    Aust N Z J Surg; 1981 Apr; 51(2):183-5. PubMed ID: 6940548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors and clinical data related to oestrogen receptor status in women presenting with breast cancer.
    Montgomery AC; McClelland RA; Skilton RA; Easton D
    Br J Surg; 1985 Aug; 72(8):629-33. PubMed ID: 4027537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The management of locally advanced carcinoma of the breast by Nolvadex (tamoxifen): a pilot study.
    Campbell FC; Morgan DA; Bishop HM; Benton FM; Blamey RW; Elston CW; Nicholson RI; Griffiths K
    Clin Oncol; 1984 Jun; 10(2):111-5. PubMed ID: 6734002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.